Posted May. 31, 2012 at 11:52 a.m.

Premium Lock Charlotte drug firm's arthritis treatment fails in trial

Published: 2012-05-31 11:52:16
Updated: 2012-05-31 11:52:16

Chelsea Chelsea

BeleagueredChelsea Therapeutics now will focus its remaining resources on an orphan drug candidate that has already fallen short of regulatory approval....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll